Document:

Termination of Management Services Agreement dated November 1, 2006

 Exhibit 10.4 
 TERMINATION OF MANAGEMENT SERVICES AGREEMENT 
 This Termination of Management Services
Agreement (the “Termination”) is entered into as of November 1, 2006, by and between CALIFORNIA RADIATION THERAPY MANAGEMENT SERVICES, INC., a California corporation (“MANAGEMENT SERVICES”) and 21ST CENTURY ONCOLOGY OF CALIFORNIA A MEDICAL CORPORATION, a California medical corporation (the “PC”). 
 WHEREAS, MANAGEMENT SERVICES and PC are parties to a Management Services Agreement dated September 8, 2006, which was assumed by MANAGEMENT SERVICES
in conjunction with MANAGEMENT SERVICES’ acquisition of certain assets from Beverly Hills Radiation Oncology also on September 8, 2006; 
 WHEREAS, MANAGEMENT SERVICES and PC wish to consolidate the Management Services Agreement dated September 8, 2006 and Management Services Agreement dated May 1, 2006 between the parties with respect to its California office
locations; and 
 WHEREAS, MANAGEMENT SERVICES and PC have entered into a Second Addendum to Management Services Agreement effective
November 1, 2006, which amends the Management Services Agreement dated May 1, 2006 to: (i) provide for the addition of the Beverly Hills location as an office location. 
 NOW THEREFORE, MANAGEMENT SERVICES and PC desire to terminate the Management Services Agreement dated September 8, 2006 between the parties
effective on the date first written above. 
  

					
	 Accepted:
	 	 CALIFORNIA RADIATION THERAPY

		 	 MANAGEMENT SERVICES, INC.

			
		 	By:	 	/s/ David M. Koeninger
		 		 	 David M. Koeninger

		 		 	 Chief Financial Officer

		
	 Accepted:
	 	
		 	21ST CENTURY ONCOLOGY OF CALIFORNIA, A MEDICAL
CORPORATION
			
		 	By:	 	/s/ Daniel E. Dosoretz
		 		 	Daniel E. Dosoretz, M.D.
		 		 	 Vice PresidentPurchase Agreement

 Exhibit 10.1 
 PURCHASE AGREEMENT 
 PURCHASE AGREEMENT, dated as of August 7, 2006 (the
“Agreement”), by and between ONEOK, Inc. (the “Issuer”), and UBS AG, London Branch (“UBS”) acting through UBS Securities LLC (“Agent”) as agent. 
 W I T N E S S E T H 
 WHEREAS, the Issuer has publicly announced its intention to repurchase shares of its common stock, par value $0.01 per share (the “Common Stock”), from time to time (the “Repurchase Program”); and

 WHEREAS, the Issuer desires to enter into the Agreement with UBS in order to effect the Repurchase Program; 

NOW, THEREFORE, in consideration of the premises, the covenants and agreements contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 
 Section 1. Definitions. 
 As used herein the following terms shall have the meanings set forth
below: 
 “Announcement Date” means in respect of a Merger Event, the date of the first public announcement of a
firm intention to merge or to make an offer that leads to the Merger Event, as determined by the Calculation Agent. 
 “Bankruptcy” means the Issuer or UBS, as the case may be, is dissolved (other than pursuant to a consolidation, amalgamation or merger); (2) becomes insolvent or is unable to pay its debts or fails or admits in writing its
inability generally to pay its debts as they become due; (3) makes a general assignment, arrangement or composition with or for the benefit of its creditors; (4) institutes or has instituted against it a proceeding seeking a judgment of
insolvency or bankruptcy or any other relief under any bankruptcy or insolvency law or other similar law affecting creditors’ rights, or a petition is presented for its winding-up or liquidation, and, in the case of any such proceeding or
petition instituted or presented against it, such proceeding or petition (A) results in a judgment of insolvency or bankruptcy or the entry of an order for relief or the making of an order for its winding-up or liquidation or (B) is not
dismissed, discharged, stayed or restrained in each case within 30 days of the institution or presentation thereof; (5) has a resolution passed for its winding-up, official management or liquidation (other than pursuant to a consolidation,
amalgamation or merger); (6) seeks or becomes subject to the appointment of an administrator, provisional liquidator, conservator, receiver, trustee, custodian or other similar official for it or for all or substantially all its assets;
(7) has a secured party take possession of all or substantially all its assets or has a distress, 

 execution, attachment, sequestration or other legal process levied, enforced or sued on or against all or
substantially all its assets and such secured party maintains possession, or any such process is not dismissed, discharged, stayed or restrained, in each case within 30 days thereafter; (8) causes or is subject to any event with respect to it
which, under the applicable laws of any jurisdiction, has an analogous effect to any of the events specified in clauses (1) to (7) (inclusive); or (9) takes any action in furtherance of, or indicating its consent to, approval of, or
acquiescence in, any of the foregoing acts. 
 “Bloomberg Screen Volume at Price Page” shall mean the display
designated as page “OKE Equity AQR” on the Bloomberg Financial Service or such page as may replace the Volume at Price page on that service for the purpose of displaying daily volume and volume-weighted trading prices of equity securities
during the normal trading hours of 9:30 a.m. to 4:00 p.m., New York Time or, if such service does not then publish daily volume and volume-weighted trading prices of the Common Stock, such other page and services selected by the Calculation Agent
that reports daily volume and weighted trading prices of the Common Stock. 
 “Borrowed Shares” means, as of any
date, the number of Shares borrowed by UBS in connection with this Transaction, as determined by the Calculation Agent. 
 “Calculation Agent” shall mean UBS Securities LLC. 
 “Calculation Date” means the first
Trading Day after the Last Averaging Date. 
 “Closing Price” of the Common Stock on any day shall mean the last
reported sales price regular way on such day or, in case no such sales price is reported on such day, the average of the reported closing bid and asked prices regular way of the Common Stock, in each case on the New York Stock Exchange, or, if not
then traded on the New York Stock Exchange, the principal securities exchange or quotation system on which the Common Stock is then listed or admitted to trading, or, if not then listed or admitted to trading on a securities exchange or quotation
system, the average of the closing bid and asked prices of the Common Stock in the over-the-counter market on the day in question as reported by the National Quotations Bureau Incorporated, or a similarly generally accepted reporting service, or, if
not so available in such manner, as furnished by any New York Stock Exchange member firm selected by the Calculation Agent. 
 “Combined Consideration” means New Shares in combination with Other Consideration. 
 “Cross
Default” means the occurrence or existence of (1) a default, event of default or other similar condition or event (however described) in respect of the Issuer under one or more agreements or instruments relating to the payment of money in
an aggregate amount of not less than $50 million which has resulted in such agreement or instrument becoming, or becoming capable at such time of being declared, due and payable before it would otherwise have been due and payable or (2) a
default by the Issuer in making one or more payments on the due date thereof in an aggregate amount of not less than $50 million under 
  
  
  

 2 

 such agreements or instruments (after giving effect to any applicable notice requirement or grace
period). 
 “Determined Amount” has the meaning ascribed to it in Section 3(d). 
 “Discount” means the amount specified as such in Schedule I hereto. 
 “Dividend Amount” shall mean, as of each of the dates set out below (each a “Dividend Adjustment Date”), the amount
set forth opposite such Dividend Adjustment Date: 
  

					
	 Dividend Adjustment Date
	  	Dividend Amount	  	
			
	 The date immediately preceding the ex-dividend
 date for the Issuer’s regularly scheduled
 fourth quarter 2006 dividend, (such ex-dividend date
currently anticipated to be October 27, 2006)
	  	$0.32	  	
			
	 The date immediately preceding the ex-dividend
 date for the Issuer’s regularly scheduled
 first quarter 2007 dividend, (such ex-dividend
date
 currently anticipated to be January 26, 2007)
	  	$0.32	  	

 “Dividend Event” means the payment of an ordinary or extraordinary
dividend of distribution by the Issuer in any of the time periods specified above with a value, as determined by the Calculation Agent in good faith, that exceeds the amount specified above for such period by $0.01 or more. 
 “Excess Shares” means the number of Shares (if any) equal to (a)(i) the Settlement Amount divided by (ii) the Reference
Price minus (b) the Determined Amount. 
 “Execution Period” shall mean the period commencing on the First
Averaging Date and ending on the earliest of (i) the Last Averaging Date, (ii) the Termination Date or (iii) the Termination Event Termination Date. 
 “Failure to Pay or Deliver” means failure by the Issuer or UBS to make, when due, any payment under this Agreement or any delivery of Shares under this Agreement required to be made by
it if such failure is not remedied on or before the third Trading Day after notice of such failure is given to the Issuer or UBS, as the case may be. 
 “Final VWAP-Minus Price” means (i) the arithmetic average of daily volume-weighted average prices of Shares on each Trading Day from the First Averaging Date up to and including the Last Averaging Date,
as listed on Bloomberg Screen Volume at Price Page, minus (ii) the Discount. 
 “First Averaging Date” means
the date specified as such in Schedule I hereto. 
  
  
  

 3 

 “Hedge Account Shares” means, as of any date, the Number of Shares minus the
Borrowed Shares. 
 “Last Averaging Date” means the date specified as such in Schedule I hereto. Notice of the
Last Averaging Date shall be given by UBS not later than 8:00 pm New York time on the Trading Day following such Last Averaging Date. Notice shall be irrevocable once provided to Issuer. 
 “Merger Event” means, in respect of any relevant Shares, any (i) reclassification or change of such Shares that results
in a transfer of or an irrevocable commitment to transfer all of such Shares outstanding, (ii) consolidation, amalgamation or merger of the Issuer with or into another entity (other than a consolidation, amalgamation or merger in which such
Issuer is the continuing entity and which does not result in any such reclassification or change of all of such Shares outstanding) or (iii) other takeover offer for such Shares that results in a transfer or an irrevocable commitment to
transfer all such Shares (other than such Shares owned or controlled by the offeror), in each case if the Merger Date is on or before the Last Averaging Date. 
 “Net Share Settlement” shall mean settlement by the Issuer of its obligations hereunder in accordance with Section 3(c). 
 “New Shares” means shares (whether of the offeror or a third party). 
 “Number of Shares” has the meaning ascribed to it in Section 2. 
 “Other Consideration” means cash and/or any securities (other than New Shares) or assets (whether of the offeror or a third
party). 
 “Payment Date” has the meaning ascribed to it in Section 3(b). 
 “Principal Account” means the notional principal account referred to in Section 3(a). 
 “Purchase Price” has the meaning ascribed to it in Section 3(a) below. 
 “Purchasing Date” means any Trading Day during the Execution Period. 
 “Reference Price” means the Closing Price of the Common Stock on the last Trading Day of the Execution Period. 
 “Settlement Amount” shall mean (i) in the case of the Issuer, the amount of any negative balance in the Principal Account
as of the Calculation Date, and (ii) in the case of UBS, the amount of any positive balance in the Principal Account as of the Calculation Date, in each case as determined by the Calculation Agent, and as adjusted by the Calculation Agent to

  
  
  

 4 

 reflect the accrual of interest thereon at the rate set forth for that day opposite the caption
“Open” under the caption “Federal Funds” as displayed on Bloomberg Page BTMM, from and excluding the third Trading Day following the Calculation Date hereunder to and including the actual Payment Date, if the Payment Date occurs
following the third Trading Day following the Calculation Date hereunder. 
 “Share-for-Combined” means, in
respect of a Merger Event, that the consideration for the relevant Shares consists of Combined Consideration. 
 “Share-for-Other” means, in respect of a Merger Event, that the consideration for the relevant Shares consists solely of Other Consideration. 
 “Share-for-Share” means, in respect of a Merger Event, that the consideration for the relevant Shares consists (or, at the option of the holder of such Shares, may consist) solely of
New Shares. 
 “Shelf Registration” means a registration statement in form and substance reasonably acceptable to
UBS for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act, registering UBS’s resale, in any manner or manners designated by UBS, of all the Stock Settlement Shares, any Make-Whole Shares, and any other
Shares held by UBS in connection with this transaction which, in the opinion of counsel to UBS, are required to be included in the Shelf Registration to be resold by UBS to the public. 
 “Short Squeeze” shall mean a situation where (i) UBS has determined, in its reasonable judgment, that it is unable to
hedge its exposure to the transaction contemplated hereby because of the lack of sufficient shares of Common Stock being made available for borrowing from lenders, including without limitation UBS’s being required to redeliver shares of Common
Stock to any lender at the demand of such lender and not being able to meet such obligation in full in a timely manner by reasonable efforts to borrow shares of Common Stock from another lender or lenders, or (ii) UBS would incur a cost to
borrow shares of Common Stock to hedge its exposure to the transaction contemplated hereby that is greater than a rate equal to 40 basis points per annum. 
 “Stock Settlement Amount” shall mean (i) in the case that the Issuer is required to pay the Settlement Amount to UBS and has elected to pay the Settlement Amount by delivery of
shares of Common Stock to UBS pursuant to Section 3(c), an amount, determined by the Calculation Agent, equal to the Settlement Amount to be paid by the Issuer pursuant to Section 3(b), divided by the Reference Price, and (ii) in the
case that UBS is required to pay the Settlement Amount to the Issuer and the Issuer has elected to require UBS to satisfy the obligation by delivery of shares of Common Stock to the Issuer pursuant to Section 3(h), an amount, determined by the
Calculation Agent, equal to the Settlement Amount to be paid by UBS pursuant to Section 3(b), divided by the weighted average price per share actually paid by UBS to purchase such Stock Settlement Shares. 
  
  
  

 5 

 “Stock Settlement Shares” shall mean such whole number of shares included in
the Stock Settlement Amount. 
 “Termination Date” has the meaning ascribed to it in Section 4(b).

 “Termination Event” shall mean the occurrence of a (i) Bankruptcy, (ii) Cross Default,
(iii) Failure to Pay or Deliver, (iv) Short Squeeze or (v) Dividend Event. 
 “Termination Event
Termination Date” has the meaning ascribed to it in Section 8 below. 
 “Trading Day” shall mean any day
on which the Common Stock is traded on the New York Stock Exchange or, if not then traded on the New York Stock Exchange, the principal securities exchange or quotation system on which such securities are then traded or, if not then traded on
a securities exchange or quotation system, in the over-the-counter market. 
  
 Section 2. Purchase and Sale. 
 Subject to the terms and conditions set
forth herein, UBS agrees to sell to the Issuer, and the Issuer agrees to purchase from UBS, 7,500,000 shares (the “Number of Shares”) of Common Stock (the “Shares”) at a purchase price per Share equal to the Closing Price of the
Common Stock on August 7, 2006 or on such other date and at such other time as the parties may mutually agree (the “Execution Date”). At 4:00 P.M. on the third Trading Day after the Execution Date (the “Settlement Date”),
UBS shall deliver or cause to be delivered the Shares through the facilities of The Depository Trust Company to the Issuer against payment by the Issuer of the Purchase Price by wire transfer of immediately available funds. The parties understand
and agree that the delivery of the Shares by or on behalf of UBS upon the payment of the Purchase Price by the Issuer is irrevocable and that as of the Settlement Date the Issuer will be the sole beneficial owner of the Shares for all purposes.

 Section 3. Settlement. 
 (a) On the Settlement Date, the Calculation Agent shall establish a notional Principal Account in an amount equal to the product of (x) the Number of Shares and (y) the Closing Price of
the Common Stock on the Execution Date (the “Purchase Price”). The Calculation Agent shall adjust the Principal Account daily as follows: 
 (i) The Principal Account shall be reduced on each Dividend Adjustment Date in an amount equal to the product of (x) the number of Borrowed Shares as of such date and (y) the Dividend Amount corresponding to
such Dividend Adjustment Date; and 
  
  
  

 6 

 (ii) The Principal Account shall be reduced on the first Trading Day following the Last
Averaging Date in an amount equal to the product of (x) 7,500,000 and (y) the Final VWAP-Minus Price. 
 On the first Trading Day
immediately following the last day of the Execution Period, the Calculation Agent will calculate the Settlement Amount and, if applicable, the Stock Settlement Amount, notify (the “Settlement Amount Notification”) the Issuer of the
Settlement Amount and, if applicable, the Stock Settlement Amount and provide a schedule of its calculations thereof. The Calculation Agent shall respond promptly to all questions raised by the Issuer relating to such calculations. If the Issuer
objects to the calculation of the Settlement Amount, the Issuer shall promptly notify the Calculation Agent, and the Issuer and UBS agree to use their good faith best efforts to reach an agreement as to the Settlement Amount. In the further event
that the Issuer and UBS are not able to reach an agreement, the Issuer and UBS shall appoint a third party with sufficient expertise to determine the calculation of the Settlement Amount, and such calculations shall be binding on both parties.

 (b)            On the third Trading Day immediately following
the Calculation Date (the “Payment Date”), if the Settlement Amount is positive, UBS shall pay the Settlement Amount to the Issuer and, if the Settlement Amount is negative, the Issuer shall pay the absolute value of such Settlement Amount
to UBS. Except as provided in paragraphs (c) and (d) of this Section, all payments to be made under this Section 3 shall be made on the Payment Date by wire transfer of immediately available funds. 
 (c)            If the Issuer is required to pay the Settlement Amount to UBS
pursuant to paragraph (b) of this Section, the Issuer may, at its option, satisfy the obligation by the delivery to UBS of a number of whole shares of Common Stock (and a payment of cash in lieu of fractional shares, if any) equal to the Stock
Settlement Amount. In order to exercise this option, the Issuer must (each, a “Condition on Net Share Settlement”) (i) notify UBS of its election to have any Settlement Amount payable in shares of Common Stock no later than the
earlier of (x) three days after UBS delivers the notice of the Last Averaging Date, (y) one day after the occurrence of a Termination Event, or (z) three days prior to February 7, 2007 if notice is not given (the “Stock
Election Notice”), (ii) enter into a registration rights agreement with UBS in form and substance reasonably acceptable to UBS (the “Registration Rights Agreement”) not later than five Trading Days prior to the date specified in
3(c)(i) above, which agreement will contain, among other things, customary representations and warranties and indemnification and other rights, including rights to customary opinions of counsel and accountant’s “comfort letters,”
relating to the registration of the Stock Settlement Shares, the Make-whole Shares and any additional shares of Common Stock as to which UBS is named as a selling securityholder in the Shelf Registration (the “Registered Shares”);
(iii) the Shelf Registration shall have been filed with the Securities and Exchange Commission not less than five Trading Days prior to the date specified in 3(c)(i) above; and (iii) maintain the effectiveness of the Shelf Registration
until all Registered Shares have been sold by UBS. Subject to paragraph 3(g) below, if any of the conditions in the preceding sentence are not met, the provisions of this paragraph (c) shall be inoperative and the Issuer shall be obligated to
pay any applicable Settlement Amount by wire transfer of immediately available funds. If the 
  
  
  

 7 

 Issuer complies with all of its obligations under this paragraph (c), then at 9:30 A.M. on the Payment
Date, the Issuer shall deliver to UBS (i) a certificate or certificates representing the fully paid and nonassessable Stock Settlement Shares, in such denominations and in such names as UBS may specify and (ii) the cash payment, if any, in
lieu of fractional shares by wire transfer of immediately available funds. The parties understand and agree that the deliveries made pursuant to the preceding sentence and the following paragraph shall be irrevocable and shall satisfy in full the
Issuer’s obligations under this Section 3; provided, however, that the Issuer shall have the right to settle pursuant to Section 3(b) in whole or, together with a settlement pursuant to this Section 3(c), in part until delivery
of the Stock Settlement Shares is made pursuant to this Section 3(c). 
 If the Issuer delivers Stock Settlement Shares to UBS pursuant
to this paragraph (c) and within fifteen Trading Days after the Payment Date, UBS resells all or any portion of the Stock Settlement Shares and the net proceeds received by UBS upon resale of such shares exceeds the Settlement Amount (or if
less than all of the Stock Settlement Shares are resold, the applicable pro rata portion of the Settlement Amount), UBS shall promptly refund in cash such difference to the Issuer; provided that UBS may, at its option, satisfy its obligation under
this sentence by returning to the Issuer any portion of the Stock Settlement Shares that would, if sold, have resulted in net proceeds in excess of the Settlement Amount. In the event that such net proceeds obtained by UBS from resales within
fifteen Trading Days after the Payment Date pursuant to the preceding sentence are less than the Settlement Amount (or if less than all of the Stock Settlement Shares are resold, the applicable pro rata portion of the Settlement Amount), the Issuer
shall pay in cash or additional shares of Common Stock (the “Make-whole Shares”) such difference (the “Make-whole Amount”) to UBS promptly after receipt of notice thereof. In the event that Issuer elects to pay the Make-whole
Amount in additional shares of Common Stock, the requirements set forth in this paragraph (c) with respect to payment of the Settlement Amount in Shares, including Make-whole requirements, shall apply, such that UBS shall pay to the Issuer any
such excess and the Issuer shall pay to UBS in cash or Make-Whole Shares any additional Make-Whole Amount. In calculating the net proceeds from the resale of any Stock Settlement Shares there shall be deducted from such proceeds any amount equal to
the customary underwriting discount or commission of 4% for underwritten offerings of common stock by companies comparable to the Issuer multiplied by the total number of Shares sold for the account of UBS pursuant to a Shelf Registration.

 (d)            Notwithstanding any other provision in this
Agreement, if Issuer exercises its right pursuant to Section 3(c) above, Issuer shall not be obliged to deliver, in connection with this Agreement, in excess of 30,000,000 shares, as recalculated from time to time (the “Determined
Amount”). In the event that, but for this Section 3, Issuer would be obliged to deliver a number of shares of Common Stock equal to the Determined Amount plus the Excess Shares, Issuer agrees to (x) satisfy its remaining
obligation by cash payment or (y) (i) use its reasonable best efforts to increase its number of authorized shares, thereby increasing the Determined Amount, to the extent necessary so that, but for this Section 3, the number of
shares of Common Stock Issuer would be obliged to deliver does not exceed the (recalculated) Determined Amount and (ii) allocate such newly authorized shares of Common Stock in satisfaction of Issuer’s delivery obligations under this
Agreement in priority to any other use of 
  
  
  

 8 

 such Common Stock. For the avoidance of doubt, the obligation of Issuer to so use its reasonable best
efforts is an ongoing obligation. 
 (e)            Issuer
hereby represents and warrants that it will: 
 (i)    calculate the Determined Amount based on the
maximum amount able to be calculated in accordance with EITF 00-19 or any successor financial statement guidance; and 
 (ii)    in respect of all equity derivative transactions in respect of which Issuer’s equity securities constitute (all or part of) the instruments underlying such transactions (the “Derivative Trades”),
use the same methodology to derive the Determined Amount (howsoever described) applicable to each Derivative Trade as is used to derive the Determined Amount for this Agreement. 
 (f)            UBS agrees that, in respect of any obligations Issuer has
duly elected be satisfied pursuant to Section 3(c) above, in the event of Issuer’s bankruptcy, UBS shall not have rights in bankruptcy that rank senior to the rights in bankruptcy of common shareholders of Issuer. 
 (g)            If the Issuer has used its reasonable best efforts to satisfy
the Conditions on Net Share Settlement but has been unable to because the Shelf Registration is not declared effective by the SEC within the time set out in paragraph 3(c) (or, where UBS has previously agreed to extend such period based on a
request by the Issuer pursuant to paragraph 3(g)(ii), within such period as extended pursuant to paragraph 3(g)(ii)), then the Issuer may elect to: 
   (i)        deliver the relevant number of Shares to UBS in which case: 
 (A)      the day on which the Issuer makes such an election to deliver such Shares is the “Issuer
Election Date”, and 
 (B)      Issuer shall withdraw any Registration Statement filed
with the SEC in connection with the Shares, and 
 (C)      Issuer will enter into a private
placement purchase agreement with UBS in form and substance reasonably acceptable to UBS no later than the next Trading Day following the Issuer Election Date, and 
 (D)      Issuer shall deliver to UBS such Shares on the Settlement Date which, for the purposes of this paragraph 3(g)(i)(D), shall be the third Trading Day
following the Issuer Election Date, and 
 (E)      in addition to any Make-whole Amount
payable by Issuer pursuant to paragraph 3(c) herein, Issuer shall deliver to UBS such additional Shares until UBS has realized actual net proceeds upon resale of such Shares equal to the Settlement Amount. At its election, UBS may by a written
notice to Issuer retain a number of Shares delivered by Issuer pursuant to this paragraph 3(g)(i). If UBS so elects, UBS shall be deemed 
  
  
  

 9 

 to have sold each such retained Share for an amount equal to the price per Share obtained by UBS for the
last Share sold by UBS prior to sending written notice of its intention to retain Shares to Issuer. The Settlement Amount shall be reduced by the net proceeds deemed to be received by UBS for each retained Share. In no event will UBS be obligated to
exercise its right to retain Shares; or 
     (ii) request UBS to extend the period within which the
Registration Statement is to be declared effective by the SEC for a further period specified in writing by UBS at the time of such extension. 
 (h)            If UBS is required to pay the Settlement Amount to the Issuer pursuant to paragraph (b) of this Section, the Issuer may, at its option,
elect that UBS satisfy the obligation by the delivery to the Issuer of a number of whole shares of Common Stock (and a payment of cash in lieu of fractional shares, if any) equal to the Stock Settlement Amount. In order to exercise this option, the
Issuer must notify UBS of its election to have any Settlement Amount payable in shares of Common Stock no later than 15 days prior to the Payment Date (the “Stock Election Notice”). If the condition in the preceding sentence is not met,
the provisions of this paragraph (h) shall be inoperative and UBS shall be obligated to pay any applicable Settlement Amount by wire transfer of immediately available funds. If the Issuer complies with all of its obligations under this
paragraph (h), then at 9:30 A.M. on the Payment Date, UBS shall deliver to the Issuer (i) a certificate or certificates representing the fully paid and nonassessable Stock Settlement Shares, and (ii) the cash payment, if any, in lieu of
fractional shares by wire transfer of immediately available funds. The parties understand and agree that the deliveries made pursuant to the preceding sentence shall be irrevocable and shall satisfy in full UBS’ obligations under this
Section 3. 
 Section 4. Anti-dilution Adjustments. 
 (a)             Subdivisions and Combinations of Common Stock. In the
event that the outstanding shares of the Common Stock shall be subdivided or split into a greater number of shares of Common Stock where the effective date of such subdivision or the record date for such split occurs during the Execution Period, the
number of shares of Common Stock referred to herein shall be deemed to be proportionately increased and the Final VWAP-Minus Price and Discount shall be deemed to be proportionately decreased; conversely, in case outstanding shares of Common Stock
shall each be combined into a smaller number of shares of Common Stock through a combination of shares of Common Stock or a reverse stock split where the effective date of such combination or the record date for such reverse stock split occurs
during the Execution Period, the number of shares of Common Stock referred to herein shall be deemed to be proportionately decreased and the Final VWAP-Minus Price and Discount shall be deemed to be proportionately increased. Any adjustment pursuant
to this paragraph (a) shall become effective (i) in the case of a subdivision or combination of the Common Stock, at the close of business on the record date for such subdivision or combination or (ii) in the case of a stock split or
reverse stock split, at the split, at the close of business on the record date for such stock split or reverse stock split. 
  
  
  

 10 

 (b)            Merger
Events. In respect of each Merger Event, UBS and the Issuer or the person formed by such consolidation or resulting from such merger or which acquired such assets or which acquires the Issuer’s Common Stock, as the case may be, shall
negotiate in good faith to amend this Agreement to give appropriate effect to such transaction. In the event that the parties are unable to reach an agreement ten (10) Trading Days prior to the effective date of such transaction (the
“Termination Date”), (i) the Execution Period shall terminate on the Termination Date, (ii) the Principal Account shall be reduced on such date by an amount equal to the product of (x) an amount equal to the cash and fair
market value (as determined by the Issuer’s Board of Directors whose good faith determination shall be conclusive and binding) of the securities and/or property payable or distributable upon such transaction in respect of one share of Common
Stock and (y) the number of Borrowed Shares as of such date, and (iii) the Settlement Amount shall be further adjusted by the Calculation Agent by the amount that the Calculation Agent reasonably determines in good faith to be UBS’s
total losses and costs in connection with the early termination of this Agreement, including any loss of bargain, cost of funding, or loss or cost incurred as a result of its terminating, liquidating, obtaining or reestablishing any hedge or related
trading position. 
 If payment is required of Issuer in connection with a Merger Event, the Issuer shall have the right, in its sole
discretion, to elect (the “Extraordinary Transaction Election”) to satisfy any such payment obligation by Net Share Settlement of this Transaction PROVIDED THAT, in connection with a “Share-for-Combined” Merger Event or
“Share-for-Other” Merger Event, the Extraordinary Transaction Election is available to satisfy only the percentage of such payment obligation equal to the percentage of the non-cash consideration over the total Combined Consideration (in
the case of a “Share-for-Combined” Merger Event) or total Other Consideration (in the case of a “Share-for-Other” Merger Event). The remaining percentage of such payment obligation must be satisfied in cash. The Issuer shall make
any election to settle the Transaction by way of Net Share Settlement within two Trading Days of the Announcement Date but in any event not less than twenty Trading Days prior to the effective date of such merger. 
 (c)            Tender Offers. In the event an offer is made to the
holders of Common Stock to tender shares of Common Stock for cash, UBS may, in its discretion (i) accelerate the Last Averaging Date or (ii) adjust the Number of Shares. UBS shall notify the Issuer in writing as to the terms of any
adjustment made pursuant to this Section 4(c) no later than 5 days after the tender offer is made. 
 (d)            Other Events. In the event of any corporate event involving the Issuer or the Common Stock not specifically addressed in subsections (a), (b) or
(c) of this Section 4 or in the event that the Calculation Agent, in its good faith judgment, determines that the adjustments described in subsections (a), (b) or (c) of this Section 4 will not result in an equitable
adjustment of the terms of the transaction described herein, and provided that, in each case, such corporate event impacts the rights or obligations of a holder of Common Stock, the terms of the transaction described herein shall be subject to
adjustment by the Calculation Agent (including, without limitation, the First Averaging Date, the Last Averaging Date and the Number of Shares) as in the exercise of its good faith judgment it deems appropriate under the 
  
  
  

 11 

 circumstances in order to result in an equitable adjustment to this transaction. In the event that the
Issuer objects to the adjustments, the Issuer shall promptly so notify the Calculation Agent and UBS, and the Issuer and UBS agree to use their good faith best efforts to reach an agreement as to the adjustment. In the further event that the Issuer
and UBS are not able to reach an agreement, the Issuer and UBS shall appoint a third party with sufficient expertise to determine the adjustment and such adjustment shall be binding on both parties. 
 Section 5. Acknowledgement. 
 The Issuer acknowledges and agrees that it is not relying, and has not relied, upon UBS or Agent with respect to the legal, accounting, tax or other implications of this Agreement and that it has
conducted its own analysis of the legal, accounting, tax and other implications of this Agreement. The Issuer further acknowledges and agrees that neither UBS nor Agent have acted as its advisor in any capacity in connection with this Agreement or
the transactions contemplated by this Agreement. The Issuer acknowledges that neither UBS nor Agent is acting as the agent for the Issuer in effecting any purchase of Common Stock pursuant to this Agreement. The Issuer understands and acknowledges
that UBS and its affiliates may from time to time effect transactions, for their own account or the account of customers, and hold positions, in securities or options on securities of the Issuer and that UBS and its affiliates may continue to
conduct such transactions during the Execution Period. 
 Section 6. Representations, Warranties and
Covenants. 
 (a)            The Issuer hereby represents
and warrants to UBS that: 
 (i) it has (or, in the case of the Registration Rights Agreement, will have when and if
executed) all power and authority to enter into this Agreement and the Registration Rights Agreement and the transactions contemplated hereby and thereby; 
 (ii) this Agreement has been duly authorized, validly executed and delivered by the Issuer and constitutes a valid and legally binding obligation of the Issuer enforceable in accordance with its
terms, subject, as to enforcement, to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles; 
 (iii) the Registration Rights Agreement, when and if executed and delivered pursuant to Section 3(c) hereof, shall have been duly
authorized, validly executed and delivered by the Issuer and shall constitute a valid and legally binding obligation of the Issuer enforceable in accordance with its terms, subject, as to enforcement, to bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles; 
 (iv) if Stock Settlement Shares are delivered pursuant to Section 3(c) or Section 3(g), as the case may be, the Stock Settlement Shares, when delivered to UBS or to 
  
  
  

 12 

 the Issuer, as the case may be, will have been duly authorized and will be duly and validly issued, fully
paid and nonassessable and free of preemptive and other rights; 
 (v) the transactions contemplated by this Agreement,
including the delivery of the Stock Settlement Shares pursuant to Section 3(c) or Section 3(g), as the case may be, are consistent with the authorization of the Repurchase Program; 
 (vi) the Issuer is not entering into this Agreement to facilitate a distribution of the Common Stock (or any security convertible into
or exchangeable for Common Stock) or in connection with a future issuance of securities; 
 (vii) the Issuer is not entering
into this Agreement to create actual or apparent trading activity in the Common Stock (or any security convertible into or exchangeable for Common Stock) or to raise or depress the price of the Common Stock (or any security convertible into or
exchangeable for Common Stock); 
 (viii) as of the date hereof and as of the date of any Stock Election Notice hereunder,
(i) none of the Issuer and its executive officers and directors is, or will be, as the case may be, aware of any material nonpublic information regarding the Issuer or the Common Stock and (ii) all reports and other documents filed by the
Issuer with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, when considered as a whole (with the more recent such reports and documents deemed to amend inconsistent statements contained in any
earlier such reports and documents), do not or will not, as the case may be, contain any untrue statement of a material fact or any omission of a material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances in which they were made, not misleading; 
 (ix) the repurchase of the Shares by the Issuer, the
compliance by the Issuer with all of the provisions of this Agreement and the consummation of the transactions herein contemplated will not conflict with or result in a breach (each, a “Breach”) of any of the terms or provisions of, or
constitute a default (each a “Default”) under, any indenture, mortgage, deed of trust, loan agreement or any other agreement or instrument to which the Issuer or any of its significant subsidiaries (as such term is defined in Rule 1-02 of
Regulation S-X) is a party (collectively, “Contracts”) or by which the Issuer or any of its significant subsidiaries is bound or to which any of the property or assets of the Issuer or any of its significant subsidiaries is subject (except
such Breach or Default as would not reasonably be expected to materially adversely affect the ability of the Issuer to perform its obligations under any Contract), nor will such action result in any violation of the provisions of the Certificate of
Incorporation or By-laws of the Issuer or any of its significant subsidiaries is subject, nor will such action result in any violation of the Certificate of Incorporation or By-laws of the Issuer or any statute or any order, rule or regulation of
any court or governmental agency or body having jurisdiction over the Issuer or any of its properties; and 
 (x) no
consent, approval, authorization, order, registration or qualification of or with any court or governmental agency or body having jurisdiction over the 
  
  
  

 13 

 Issuer or any of its properties is required for the repurchase of the Shares by the Issuer, the
compliance by the Issuer with all the terms of this Agreement, or the consummation by the Issuer of the transactions contemplated by this Agreement, other than the registration of the Stock Settlement Shares and any Make-whole Shares under the
Securities Act in accordance with the provisions of Section 3(c), which registration shall be completed not less than five Trading Days prior to the date specified in clause (i) of Section 3(c) above, and such authorizations, orders,
registrations and qualifications as may be required under state securities or blue sky laws in connection with the resale by UBS of the Registered Shares. 
 (b)              UBS hereby represents and warrants and, in the case of (iv) and (v), covenants to the Issuer:

 (i) it has all power and authority to enter into this Agreement and the Registration Rights Agreement and the
transactions contemplated hereby and thereby; 
 (ii) this Agreement has been duly authorized, validly executed and
delivered by UBS and constitutes a valid and legally binding obligation of UBS enforceable in accordance with its terms, subject, as to enforcement, to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of
general applicability relating to or affecting creditors’ rights and to general equity principles; 
 (iii) the
Registration Rights Agreement, when and if executed and delivered pursuant to Section 3(c) hereof, shall have been duly authorized, validly executed and delivered by UBS and shall constitute a valid and legally binding obligation of UBS
enforceable in accordance with its terms, subject, as to enforcement, to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general
equity principles; 
 (iv) it is not entering into this Agreement, and it will not effect any transactions contemplated
herein with the intention to raise or depress or otherwise manipulate the price of the Shares (or any security convertible or exchangeable for Shares) in violation of Section 9(a) or Section 10 of the Exchange Act, and it will maintain
such reasonable policies and procedures as are necessary to fulfill this clause (iv) of Section 6(b) during the term of this Agreement; and 
 (v) it has implemented, and will maintain, reasonable policies and procedures, taking into consideration the nature of its business, to ensure that individuals making trading decisions in connection with the the
Seller’s hedging activities hereunder would not violate laws prohibiting trading on the basis of material non-public information. 
 Section 7. Indemnification. 
 In the event that UBS becomes involved in
any capacity in any action, proceeding or investigation brought by or against any person in connection with any matter 
  
  
  

 14 

 referred to in this Agreement, the Issuer periodically will reimburse UBS for its legal and other
expenses (including the cost of any investigation and preparation) incurred in connection therewith, except to the extent that any such action, proceeding or investigation results from the gross negligence or bad faith of UBS in effecting the
transactions that are the subject of, or otherwise are connected with, this Agreement. The Issuer also will indemnify and hold UBS harmless against any losses, claims, damages or liabilities to which UBS may become subject in connection with any
matter referred to in this Agreement, except to the extent that any such loss, claim, damage or liability results from the gross negligence or bad faith of UBS in effecting the transactions which are the subject of this Agreement. If for any reason
the foregoing indemnification is unavailable to UBS or insufficient to hold it harmless, then the Issuer shall contribute to the amount paid or payable by UBS as a result of such loss, claim, damage or liability in such proportion as is appropriate
to reflect the relative benefits received by the Issuer on the one hand and UBS on the other hand in the matters contemplated by this Agreement as well as the relative fault of the Issuer and UBS with respect to such loss, claim, damage or liability
and any other relevant equitable considerations. The relative benefits to the Issuer, on the one hand, and UBS, on the other hand, shall be in the same proportion as the Aggregate Purchase Price bears to the commissions received by UBS pursuant to
the last paragraph of Section 2. The reimbursement, indemnity and contribution obligations of the Issuer under this Section 7 shall be in addition to any liability which the Issuer may otherwise have, shall extend upon the same terms and
conditions to any affiliate of UBS and the partners, directors, officers, agents, employees and controlling persons (if any), as the case may be, of UBS and any such affiliate and shall be binding upon and inure to the benefit of any successors,
assigns, heirs and personal representatives of the Issuer, UBS, any such affiliate and any such person. The Issuer also agrees that neither UBS nor any of such affiliates, partners, directors, officers, agents, employees or controlling persons shall
have any liability to the Issuer for or, in connection with any matter referred to in this Agreement except to the extent that any losses, claims, damages, liabilities or expenses incurred by the Issuer result from the gross negligence or bad faith
of UBS in effecting the transactions that are the subject of this Agreement. The foregoing provisions shall survive any termination or completion of this Agreement. 
 Section 8. Termination Event. 
 Upon the
occurrence of (i) a Bankruptcy by UBS or a Failure to Pay or Deliver by UBS and so long as such Bankruptcy or Failure to Pay or Deliver is continuing or (ii) a Termination Event involving the Issuer and so long as the Termination Event
shall be continuing, the Issuer or UBS may, respectively, in each party’s discretion, by notice to the other party (the date of such notice and the notice referred to in the succeeding clause being referred to herein as the “Notice
Date”), direct that the Execution Period shall forthwith terminate on the date specified in such notice (the “Termination Event Termination Date”) (where such date shall be selected in a commercially reasonable manner under the
circumstances). In such an event, (i) the Execution Period shall terminate on the Termination Event Termination Date, (ii) the Principal Account shall be reduced on such date by an amount equal to the sum of (A) the product of
(x) the number of Hedge Account Shares and (y) the arithmetic average of daily volume-weighted average prices of Shares in each Trading Day from the First Averaging Date up to and excluding the Notice Date, as listed on Bloomberg

  
  
  

 15 

 Screen Volume at Price Page and (B) the total purchase price paid by UBS for the Shares of Common
Stock that are purchased by UBS during the period commencing on and including the Notice Date to and including the Termination Event Termination Date in order to cover the remaining number of Borrowed Shares, (iii) the Principal Account shall
be increased to reflect an appropriate accrual of interest at the Federal Funds Open Rate, as determined by the Calculation Agent, to reflect interest earned by UBS in respect of the aggregate Purchase Price received from the Issuer, (iv) the
Principal Account shall be decreased to reflect UBS’s actual cost of borrowing shares of Common Stock to hedge its obligations hereunder, and (v) the Settlement Amount shall be further adjusted by the amount that UBS reasonably determines
in good faith to be its total losses and costs in connection with the early termination of this Agreement, including any loss of bargain, cost of funding, or loss or cost incurred as a result of its terminating, liquidating, obtaining or
reestablishing any hedge or related trading position. 
 Section 9. Miscellaneous. 
 (a)             Severability. If any term, provision, covenant or
restriction of this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and obligations set forth herein shall remain in full force and effect and shall in no
way be affected, impaired or invalidated. 
 (b)            
Assignment. Neither the rights under this Agreement nor the obligations created by this Agreement shall be assignable or delegable, in whole or in part, by either party hereto without the prior written consent of the other (which consent
shall not be unreasonably withheld), and any attempt to assign or delegate any rights or obligations arising under this Agreement without such consent shall be void. 
 (c)             Waivers, etc. No failure or delay on the part of either party in exercising any power or right hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any
other right or power. No amendment, modification or waiver of any provision of this Agreement nor consent to any departure by either party therefrom shall in any event be effective unless the same shall be in writing and, in the case of a waiver or
consent, shall be effective only in the specific instance and for the purpose for which given. 
 (d)             Beneficiaries. This Agreement shall be binding upon, and inure solely to the benefit of, the Issuer, UBS and, to the extent provided in Section 7
hereof, the affiliates, partners, directors, officers, agents, employees and controlling persons, if any, of UBS, and their respective successors, assigns, heirs and personal representatives, and no other person shall acquire any rights hereunder.

 (e)             Limitation of Set-Off. For the
avoidance of doubt, UBS waives any right of set-off, recoupment or close-out netting that it may be entitled to under any agreement relating to the transactions that are the subject of this Agreement or any applicable law. 
  
  
  

 16 

 (f)             Changes
of Law. If, due to any change in applicable law or regulations or the interpretation thereof by any court of law or other body having jurisdiction subsequent to the date of this Agreement, performance of any provision of this Agreement or any
transaction contemplated thereby shall become impracticable or impossible, the parties hereto shall use their best efforts to find and employ an alternative means to achieve the same or substantially the same result as contemplated by such
provision. 
 (g)             Confidentiality. Subject to
Section 5, to any contrary requirement of law and to the right of each party to enforce its rights hereunder in any legal action, each party shall keep strictly confidential and shall cause its employees and agents to keep strictly confidential
the terms of this Agreement and any information of or concerning the other party which it or any of its agents or employees may acquire pursuant to, or in the course of performing its obligations under, any provision of this Agreement. In the event
disclosure is permitted pursuant to the preceding sentence, the disclosing party shall (i) provide prior notice of such disclosure to the other party, (ii) use its best efforts to minimize the extent of such disclosure and
(iii) comply with all reasonable requests of the other party to minimize the extent of such disclosure. This Section 9(g) shall not prevent either party from disclosing information as necessary to third-party advisors in connection with
the transactions contemplated hereby provided that such advisors agree to be bound by this Section 9(g) as if a party hereto. 
 (h)             Agent. UBS Securities LLC shall act as “agent” for UBS and the Issuer within the meaning of Rule 15a-6 under the Exchange Act. The Agent is not a
principal to this Agreement and shall have no responsibility or liability to UBS or the Issuer in respect of this Agreement, including, without limitation, in respect of the failure of UBS or the Issuer to pay or perform under this Agreement. Each
of UBS and the Issuer agrees to proceed solely against the other to collect or recover any securities or money owing to it in connection with or as a result of this Agreement. The Agent shall otherwise have no liability in respect of this Agreement,
except for its gross negligence or willful misconduct in performing its duties as Agent hereunder. As a broker-dealer registered with the Securities and Exchange Commission, UBS Securities LLC, in its capacity as agent, will be responsible for
(i) effecting the transaction contemplated in this Agreement, (ii) issuing all required notices, confirmations and statements to Buyer and Seller and (iii) maintaining books and records relating to this Agreement. 
 (i)             Headings. Descriptive headings herein are for
convenience only and shall not control or affect the meaning or construction of any provision of this Agreement. 
 (j)             Counterparts. This Agreement may be executed by the parties hereto in counterparts, and each such executed counterpart shall be, and shall be deemed to be,
an original instrument and all such counterparts, taken together, shall constitute one and the same instrument. 
 (k)             Notices. All notices, consents, requests, instructions, approvals and other communications provided for herein shall be validly given, made or served if in
writing 
  
  
  

 17 

 and delivered personally, by telegram, by telecopy or sent by overnight courier, postage prepaid, to:

  

			
	 UBS AG, London Branch at:

	
	 c/o UBS Securities LLC

	 677 Washington Boulevard

	 Stamford, CT 06901

	 Attention of: Adam Frieman

	 Fax Number: 203-719-7031

	
	 With a copy to such address to attention of:

	 Legal and External Affairs

		
	 the Issuer at:
	  	 100 West Fifth Street

		  	 Tulsa, OK 74103

		  	 United States

		
	 Attention of:
	  	 Caron Lawhorn

	 Fax Number:
	  	 918 588 7960

		
	 With a copy to:
	  	 John Barker

		  	 General Counsel

		  	 100 West Fifth Street

		  	 Tulsa, OK 74103

		  	 United States

	 Fax Number:
	  	 918 588 7971

 or to such other address as any party may, from time to time, designate in a written notice given
in a like manner. Notice given by telegram or telecopy shall be deemed delivered when evidence of the transmission is received by the sender and shall be confirmed in writing by overnight courier, postage prepaid. Notice given by overnight courier
as set out above shall be deemed delivered the business day after the date the same is mailed. 
  

			
	 (l)
	  	 Account Details.

		
		  	 UBS:

		
		  	 Cash Payments for Stock Purchase

		  	 Citibank, New York

		  	 ABA# 021 000 089

		  	 A/C# 4065 2556

		  	 UBS Securities, LLC

  

 18 

			
		  	 Cash Payments for Settlement

		  	 UBS AG Stamford

		  	 f/o UBS AG London Branch

		  	 ABA# 026-007-993

		  	 AC# 101-WA-140007-000

		
		  	 Issuer:

		
		  	 To be advised separately

 (m)            Non-Confidentiality. The parties hereby agree that (i) effective from the date of the commencement of discussions concerning the transactions
contemplated by this Agreement, the Issuer and each of its employees, representatives, or other agents may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of such transactions and all materials of
any kind, including opinions or other tax analysis, provided by UBS and its affiliates to the Issuer relating to such tax treatment and tax structure, and (ii) UBS does not assert a claim of proprietary ownership in respect of any description
contained herein or therein relating to the use of any entities, plans or arrangements to give rise to a particular United States federal income tax treatment for the Issuer. 
 (n)            Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the
state of New York without reference to conflict of law principles. Each party hereto irrevocably submits to the extent permitted under applicable law to the non-exclusive jurisdiction of the federal and state courts located in the Borough of
Manhattan, State of New York. Each party waives, to the fullest extent permitted by applicable law, any right it may have to a trial by jury in respect of any suit, action or proceeding relating to this Agreement. 
 (o)            Entire Agreement. This constitutes the entire
agreement and understanding of the parties with respect to the subject matter hereof and supersedes all oral communications and prior writing with respect thereto. 
 IN WITNESS WHEREOF, UBS and the Issuer have caused this Agreement to be duly authorized, executed and delivered as of the date first written above. 
  

			
	 UBS AG, LONDON BRANCH

	
	 By: /s/ Dmitriy Mandel

	     Name: Dmitriy Mandel

	     Title: Executive Director

	
	 By: /s/ Akshay Mansukhani

	     Name: Akshay Mansukhani

	     Title: Associate Director

  
  
  

 19 

			
	 UBS SECURITIES LLC

	
	 By: /s/ Dmitriy Mandel

	     Name: Dmitriy Mandel

	     Title: Executive Director

	
	 By: /s/ Akshay Mansukhani

	     Name: Akshay Mansukhani

	     Title: Associate Director

	
	 ONEOK, INC.

	
	 By: /s/ Jim Kneale

	     Name: Jim Kneale

	     Title: Executive Vice President-
               Finance and Administration and

	               Chief Financial Officer

  
  
  

 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00112-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00112-of-00352.parquet"}]]